Science Explorer Interactive view Map
Company · Amadora · Portugal

Roche (Portugal)

roche.ptROR OpenAlex
Research works
28
▲ 45% vs 2013–17
Citations
198
7.0 per fractional work
Top-10% rate
7.3%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: Roche (Portugal) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.30× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 4.25× its world share, 0 worksImmunology and Micro…Computer Science: 0.17× its world share, 0 worksComputer ScienceHealth Professions: 1.13× its world share, 0 worksHealth ProfessionsMedicine: 3.16× its world share, 6 worksMedicineDecision Sciences: 1.11× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 9.64× its world share, 2 worksEconomics, Econometr…Social Sciences: 0.16× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 9.6×. Every wedge is a field page.

Which keywords describe research at Roche (Portugal)?

By fractional works in all years, weighted toward what it does more of than the world: Cost of Care, Financial Toxicity, Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Chemotherapy, Rituximab and Clinical Trials.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Cost of Care4▲ 703×1 topic
  2. Financial Toxicity4▲ 703×1 topic
  3. Quality of Life4▲ 9.4×5 topics
  4. Cost-effectiveness Analysis3▲ 116×1 topic
  5. Health Utility Measures3▲ 116×1 topic
  6. Chemotherapy2▲ 11×7 topics
  7. Clinical Trials2▲ 11×6 topics
  8. Rituximab2▲ 42×2 topics
  9. Epidemiology2▲ 1.57×11 topics
  10. Prognostic Factors2▲ 12×5 topics
  11. Breast Cancer1▲ 17×4 topics
  12. Clinical Practice Guidelines1▲ 8.6×4 topics
  13. Lymphoma1▲ 32×2 topics
  14. PET Imaging1▲ 20×3 topics
  15. Classification1▲ 12×1 topic
  16. Molecular Profiling1▲ 36×1 topic
  17. Molecular Subtypes1▲ 47×2 topics
  18. Targeted Therapy1▲ 19×4 topics
  19. Clinical Outcomes1▲ 19×2 topics
  20. Radiotherapy1▲ 9.9×2 topics
  21. Factor VIII1▲ 210×1 topic
  22. Hemophilia1▲ 210×1 topic
  23. Precision Medicine1▲ 11×2 topics

Which research topics does Roche (Portugal) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer, Artificial Intelligence in Healthcare and Education and Women's cancer prevention and management.

Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksEconomic and Financial Impacts of Cancer: 1 fractional worksArtificial Intelligence in Healthcare and Education: 0 fractional worksWomen's cancer prevention and management: 0 fractional worksHepatocellular Carcinoma Treatment and Prognosis: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksColorectal Cancer Treatm…0Colorectal Cancer Treatments and Studies: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksCholangiocarcinoma and Gallbladder Cancer Studies: 0 fractional worksMultiple and Secondary Primary Cancers: 0 fractional works
Economics and EconometricsHealth InformaticsPublic Health, Environmental and Occupational HealthHepatology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  2. 2 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  3. 3 Artificial Intelligence in Healthcare and Education Health Informatics 0 works
  4. 4 Women's cancer prevention and management Public Health, Environmental and Occupational Health 0 works
  5. 5 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
  6. 6 HER2/EGFR in Cancer Research Oncology 0 works
  7. 7 Colorectal Cancer Treatments and Studies Oncology 0 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 0 works
  9. 9 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
  10. 10 Multiple and Secondary Primary Cancers Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.3%not open45.7%

World: 28% of research is openly available.

with international co-authors45.4%domestic only54.6%

World: 19% is written across borders.

How has Roche (Portugal)'s research output changed?

Output in 2018–2022 was 45% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Amadora

All research institutions in Amadora

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.